(Q51609733)

English

Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome.

scientific article published on 25 January 2011

Statements

Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit